Looking at the Narrative for ZoomInfo After Analyst Shifts and New AI Initiatives

ZoomInfo Technologies’ price target has seen only marginal movement, as analysts kept their fair value estimate nearly flat while slightly raising the discount rate. This reflects a delicate balance between cautious optimism and lingering concerns following the company’s latest quarterly results. Stay tuned to discover how you can follow ongoing shifts in ZoomInfo’s investment narrative as market expectations evolve.

Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value ZoomInfo Technologies.

???? Bullish Takeaways

Several analysts have increased their price targets for ZoomInfo Technologies following the company's latest earnings. Notably, Barclays raised its target to $14 from $13, and Citi raised its target to $13 from $11. Both firms are maintaining a neutral or equal weight stance, but these moves signal growing confidence in the company’s trajectory.

Analysts from Citi and UBS noted improved momentum in the business. They pointed to above-average performance in the latest quarter, sequential improvements among down-market customers, and steady growth prospects.

Barclays highlighted stability in ZoomInfo’s down-market operations and improving upsell momentum, particularly with new offerings such as Copilot and Operations. This suggests ongoing success in product execution and customer expansion.

BofA became more constructive on the company’s execution potential after "good" Q3 results, although it remains cautious relative to peers.

Across coverage, analysts cited the company’s upmarket progress and the potential of AI-driven offerings as bright spots for future growth.

???? Bearish Takeaways

Despite improved price targets, both Goldman Sachs and BofA maintained less optimistic ratings (Sell and Underperform, respectively). These ratings reflect concerns that revenue acceleration remains modest and that larger customer additions are limited.

Goldman Sachs, while raising its target to $10.70 from $9.40, noted that overall progress was insufficient for a major re-rating. The firm emphasized continued down-market weakness as an overhang on growth prospects.

Wells Fargo initiated coverage with an Underweight rating and a $10 target, citing mixed upmarket momentum, uncertainty among SMB customers, and competitive pressures in the evolving AI landscape.

Reservations were also raised about unproven upside from emerging products. Some analysts want to see more robust improvement in free cash flow and margins before turning fully positive.

Overall, while analysts are incrementally more positive and price targets have moved higher, many maintain a wait-and-see approach as they monitor execution consistency, customer expansion, and proof points from new offerings before upgrading their outlook for ZoomInfo Technologies.

Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives or begin writing your own Narrative!

ZoomInfo Technologies launched the AI Builder Catalog, a new tool that helps recruiters identify outstanding AI talent by highlighting verifiable signals from open source contributions, academic work, patents, and technical communities.

The company announced a strategic partnership with Markaaz. Together, they plan to launch an AI-powered B2B data platform in January 2026. This platform aims to combine sales intelligence with credit and risk data to support enterprise organizations.

ZoomInfo introduced Copilot Workspace, an AI-powered platform designed to help revenue teams manage go-to-market strategies and workflow automation. The platform offers unified, AI-driven insights.

The company completed share repurchases totaling nearly 70 million shares, representing just over 20% of total shares, for $749.42 million as part of its ongoing buyback program.

Fair Value: Remained nearly flat at $12.35 per share, indicating stable analyst consensus on intrinsic worth.

Discount Rate: Increased slightly from 9.22% to 9.57%, suggesting marginally higher perceived risk or required return.

Revenue Growth: Declined moderately from 4.36% to 3.86%, reflecting lowered expectations for sales expansion over time.

Net Profit Margin: Improved slightly from 14.77% to 15.24%, indicating expectations for stronger profitability.

Future P/E: Dropped from 20.65x to 19.19x, signaling a modest reduction in the company’s forward earnings multiple.

Narratives are a smarter, more dynamic way to invest. They reveal the story behind a company’s numbers by connecting business catalysts, financial forecasts, and fair value estimates. Narratives make it easy to track a company’s journey. On Simply Wall St’s Community page, millions follow and update these story-driven forecasts, helping investors quickly spot when Fair Value and Price diverge. Narratives are refreshed automatically as new news or earnings emerge, guiding timely buy and sell decisions.

Read the original Narrative on ZoomInfo Technologies to stay in sync with the company’s evolving story and financial outlook: GTM: Future Revenue Will Depend On Upside From New AI Segment

See how accelerating AI adoption and new offerings are shaping ZoomInfo’s revenue growth and profit margins over the next several years.

Understand the impact of ZoomInfo’s upmarket focus and customer retention efforts on its long-term financial health.

Monitor critical risks, from large client concentration to data regulations, and how changes in these could affect the company’s Fair Value and growth prospects.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include GTM.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Scroll to Top